CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 132 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $238,227 | -30.1% | 5,345 | -56.0% | 0.16% | -30.6% |
| Q3 2022 | $341,000 | +65.5% | 12,135 | +59.1% | 0.24% | +59.9% |
| Q2 2022 | $206,000 | -21.1% | 7,625 | -0.7% | 0.15% | -11.4% |
| Q1 2022 | $261,000 | -17.4% | 7,675 | -6.2% | 0.17% | -14.4% |
| Q4 2021 | $316,000 | +6.8% | 8,183 | +49.1% | 0.19% | 0.0% |
| Q3 2021 | $296,000 | +37.7% | 5,489 | -14.4% | 0.19% | +47.0% |
| Q2 2021 | $215,000 | -17.0% | 6,416 | -56.6% | 0.13% | -25.4% |
| Q4 2020 | $259,000 | +38.5% | 14,791 | +17.6% | 0.18% | +17.2% |
| Q3 2020 | $187,000 | – | 12,581 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |